This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Ki-1+ Anaplastic Large Cell Lymphoma
Information about Ki-1+ Anaplastic Large Cell Lymphoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Ki-1+ Anaplastic Large Cell Lymphoma
Most recent studies have shown that Ki-1+ Anaplastic Large Cell Lymphoma shares some biological mechanisms with anaplastic-lymphoma, b-cell-lymphomas, carcinoma, chromosomal-translocation, diffuse-large-b-cell-lymphoma, hodgkin-disease, leukemia, lymphoma, lymphoma-non-hodgkin, lymphoma-primary-cutaneous-anaplastic-large-cell, lymphoma-t-cell-cutaneous, lymphomatoid-papulosis, lymphoproliferative-disorders, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasms, peripheral-t-cell-lymphoma, skin-neoplasms, t(2;5)(p23;q35), t-cell-lymphoma.
Among the many pathways, these few ones have gauged particular interests from scientists studying Ki-1+ Anaplastic Large Cell Lymphoma, and have been seen in publications frequently: Cell Activation, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Differentiation, Cell Growth, Cell Proliferation, Coagulation, Immune Response, Induction Of Apoptosis, Interphase, Localization, Methylation, Oncogenesis, Pathogenesis, Reverse Transcription, Rna Interference, Secretion, Translation, Transport
Quite a number of genes have been found to play important roles in Ki-1+ Anaplastic Large Cell Lymphoma, such as ACVRL1, ALK, CD4, CDK5R1, CTLA4, ETFA, HLA-DQA1, KRT20, MS4A1, MUC1, NOD2, NPM1, PTGES3, PTPRC, RRAS, TMED10, TNFRSF8, TPT1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.